• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 CXCR4 的 68Ga- Pentixafor PET/CT 成像在炎症性肠病中的应用。

CXCR4-Targeted 68 Ga-Pentixafor PET/CT Imaging in Inflammatory Bowel Disease.

机构信息

From the PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University.

出版信息

Clin Nucl Med. 2024 Sep 1;49(9):817-821. doi: 10.1097/RLU.0000000000005374. Epub 2024 Jul 31.

DOI:10.1097/RLU.0000000000005374
PMID:39086048
Abstract

PURPOSE

To investigate the role of CXCR4-targeted 68 Ga-pentixafor PET/CT imaging in inflammatory bowel disease (IBD).

METHODS

Five IBD patients and 12 control subjects performing 68 Ga-pentixafor PET/CT examinations were included. 68 Ga-pentixafor PET/CT imaging and endoscopic findings were recorded and compared. The semiquantitative parameters of 68 Ga-pentixafor uptake by the lesion segments in IBD patients and the normal intestines in the control were investigated.

RESULTS

Among these 5 IBD patients, endoscopy successfully examined a total of 26 intestinal segments, with 13 segments showing endoscopic lesions. 68 Ga-pentixafor PET/CT was positive in all endoscopy-proven lesions (13/13). Additionally, 68 Ga-pentixafor PET/CT revealed the lesions in small intestines and colons that cannot be reached by endoscopy due to severe stenosis, and mesenteric lymphadenitis accompanied IBD. The SUV max of the lesion segments in IBD patients was significantly higher than that of the normal intestines in the control group (median, 3.15 [range, 1.61-6.26] vs 1.67 [1.18-2.29], P < 0.001). Moreover, the SUV max ratios of the lesion segments/liver or blood pool were higher when compared with the control (2.20 [1.13-3.26] vs 0.85 [0.54-1.20]; 1.66 [0.94-2.95] vs 0.67 [0.52-1.04]; P ≤ 0.001).

CONCLUSIONS

68 Ga-pentixafor PET/CT can be a potentially valuable tool to assess the active intestinal lesions of IBD with high sensitivity. Moreover, this noninvasive approach does not require fasting or bowel preparation, offering good tolerance and safety.

摘要

目的

研究 CXCR4 靶向的 68Ga-戊替克斯佛 PET/CT 成像在炎症性肠病(IBD)中的作用。

方法

纳入 5 例 IBD 患者和 12 例进行 68Ga-戊替克斯佛 PET/CT 检查的对照者。记录并比较 68Ga-戊替克斯佛 PET/CT 成像和内镜检查结果。研究 IBD 患者病变节段和对照者正常肠段对 68Ga-戊替克斯佛摄取的半定量参数。

结果

在这 5 例 IBD 患者中,内镜成功检查了总共 26 个肠段,其中 13 个肠段有内镜下病变。68Ga-戊替克斯佛 PET/CT 对所有经内镜证实的病变(13/13)均呈阳性。此外,68Ga-戊替克斯佛 PET/CT 显示了由于严重狭窄而无法通过内镜到达的小肠和结肠病变以及伴有 IBD 的肠系膜淋巴结炎。IBD 患者病变节段的 SUVmax 明显高于对照者的正常肠段(中位数,3.15[范围,1.61-6.26] vs 1.67[1.18-2.29],P<0.001)。此外,与对照者相比,病变节段/肝脏或血池的 SUVmax 比值更高(2.20[1.13-3.26] vs 0.85[0.54-1.20];1.66[0.94-2.95] vs 0.67[0.52-1.04];P≤0.001)。

结论

68Ga-戊替克斯佛 PET/CT 可能是一种评估 IBD 活动性肠内病变的高灵敏度、有潜在价值的工具。此外,这种非侵入性方法不需要禁食或肠道准备,具有良好的耐受性和安全性。

相似文献

1
CXCR4-Targeted 68 Ga-Pentixafor PET/CT Imaging in Inflammatory Bowel Disease.靶向 CXCR4 的 68Ga- Pentixafor PET/CT 成像在炎症性肠病中的应用。
Clin Nucl Med. 2024 Sep 1;49(9):817-821. doi: 10.1097/RLU.0000000000005374. Epub 2024 Jul 31.
2
68 Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results.68Ga- 培哚普利 PET/CT 用于胶质瘤中 CXCR4 受体的体内成像,显示出对放化疗反应评估的潜力:初步结果。
Clin Nucl Med. 2024 Apr 1;49(4):e141-e148. doi: 10.1097/RLU.0000000000005073. Epub 2024 Feb 1.
3
68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.68Ga-PSMA-11 PET/CT 成像在脑胶质瘤中的应用及其与临床病理预后参数的相关性。
Clin Nucl Med. 2023 Dec 1;48(12):e559-e563. doi: 10.1097/RLU.0000000000004903. Epub 2023 Oct 23.
4
Chemokine Receptor 4-Targeted PET/CT With 68 Ga-Pentixather Detects More Lesions Than 68 Ga-Pentixafor PET/CT in Multiple Myeloma.靶向趋化因子受体 4 的 68Ga-戊替他肽 PET/CT 比 68Ga-戊昔妥昔肽 PET/CT 检测多发性骨髓瘤的病灶更多。
Clin Nucl Med. 2024 Jun 1;49(6):592-593. doi: 10.1097/RLU.0000000000005194. Epub 2024 Apr 17.
5
Reduced splenic uptake of [Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma.一线化疗后[镓]镓-喷替沙氟脾摄取降低与新诊断的多发性骨髓瘤患者预后不良相关。
EJNMMI Res. 2025 Jun 20;15(1):74. doi: 10.1186/s13550-025-01262-2.
6
Potential Efficacy of 68 Ga-Trivehexin PET/CT and Immunohistochemical Validation of αvβ6 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma and Pancreatic Ductal Adenocarcinoma.68Ga-三肽替普素 PET/CT 的潜在疗效及对头颈鳞癌和胰腺导管腺癌患者αvβ6 整合素表达的免疫组化验证。
Clin Nucl Med. 2024 Aug 1;49(8):733-740. doi: 10.1097/RLU.0000000000005278. Epub 2024 May 14.
7
Imaging Inflammation in Atherosclerosis with CXCR4-Directed Ga-Pentixafor PET/CT: Correlation with F-FDG PET/CT.用 CXCR4 导向的 Ga-培替唑珠单抗 PET/CT 成像动脉粥样硬化中的炎症:与 F-FDG PET/CT 的相关性。
J Nucl Med. 2020 May;61(5):751-756. doi: 10.2967/jnumed.119.234484. Epub 2019 Oct 25.
8
68 Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.68Ga-FAPI-04 PET/CT 用于 FDG 亲和力低的特定乳腺癌患者:一项头对头对比研究。
Clin Nucl Med. 2023 Sep 1;48(9):e420-e430. doi: 10.1097/RLU.0000000000004751. Epub 2023 Jun 23.
9
The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors.长效生长抑素类似物对神经内分泌肿瘤患者 68Ga-DOTATATE 摄取的影响。
Clin Nucl Med. 2023 Sep 1;48(9):757-762. doi: 10.1097/RLU.0000000000004776. Epub 2023 Jul 22.
10
Performance of Pentixafor PET/CT in identifying unilateral primary aldosteronism: A meta-analysis.培五新用于正电子发射断层显像/计算机断层扫描(PET/CT)鉴别单侧原发性醛固酮增多症的效能:一项荟萃分析
Eur J Radiol. 2025 Sep;190:112240. doi: 10.1016/j.ejrad.2025.112240. Epub 2025 Jun 14.

引用本文的文献

1
CD45-targeted PET enables the visualization of inflammatory conditions.靶向CD45的正电子发射断层扫描(PET)能够实现炎症状态的可视化。
Am J Nucl Med Mol Imaging. 2025 Jun 25;15(3):124-129. doi: 10.62347/VFWR2835. eCollection 2025.